Cost-effectiveness of treatment with etanercept for psoriasis in Sweden
- 6 March 2011
- journal article
- Published by Springer Science and Business Media LLC in The European Journal of Health Economics
- Vol. 13 (2), 145-156
- https://doi.org/10.1007/s10198-010-0293-8
Abstract
To estimate the cost-effectiveness, from a Swedish societal perspective, of intermittent use of etanercept (Enbrel) with interruptions of use after 24 weeks compared to continuous use of adalimumab (Humira) as well as non-systemic standard of care in patients with moderate to severe psoriasis.Keywords
This publication has 36 references indexed in Scilit:
- Economic evaluation of systemic therapies for moderate to severe psoriasisBritish Journal of Dermatology, 2009
- Adalimumab therapy for moderate to severe psoriasis: A randomized, controlled phase III trialJournal of the American Academy of Dermatology, 2008
- Cost-effectiveness of biologic treatments for psoriasis based on subjective and objective efficacy measures assessed over a 12-week treatment periodJournal of the American Academy of Dermatology, 2008
- Adalimumab treatment is associated with improvement in health‐related quality of life in psoriasis: Patient‐reported outcomes from a Phase II randomized controlled trialJournal of Dermatological Treatment, 2007
- Clinical response to adalimumab treatment in patients with moderate to severe psoriasis: Double-blind, randomized controlled trial and open-label extension studyJournal of the American Academy of Dermatology, 2006
- Patients with psoriasis respond to continuous open-label etanercept treatment after initial incomplete response in a randomized, placebo-controlled trialJournal of the American Academy of Dermatology, 2006
- Current severe psoriasis and the Rule of TensBritish Journal of Dermatology, 2005
- The efficacy and safety of etanercept in the re-treatment of psoriasis after relapseJournal of the American Academy of Dermatology, 2004
- Treatment of psoriasis. Part 2. Systemic therapiesJournal of the American Academy of Dermatology, 2001
- Feelings of stigmatization in patients with psoriasisJournal of the American Academy of Dermatology, 1989